85
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A primary immunodeficiency syndrome caused by loss-of-function mutations in the IL-21 receptor exhibits impaired B, T, and NK cell function.

          Abstract

          Primary immunodeficiencies (PIDs) represent exquisite models for studying mechanisms of human host defense. In this study, we report on two unrelated kindreds, with two patients each, who had cryptosporidial infections associated with chronic cholangitis and liver disease. Using exome and candidate gene sequencing, we identified two distinct homozygous loss-of-function mutations in the interleukin-21 receptor gene ( IL21R; c.G602T, p.Arg201Leu and c.240_245delCTGCCA, p.C81_H82del). The IL-21R Arg201Leu mutation causes aberrant trafficking of the IL-21R to the plasma membrane, abrogates IL-21 ligand binding, and leads to defective phosphorylation of signal transducer and activator of transcription 1 (STAT1), STAT3, and STAT5. We observed impaired IL-21–induced proliferation and immunoglobulin class-switching in B cells, cytokine production in T cells, and NK cell cytotoxicity. Our study indicates that human IL-21R deficiency causes an immunodeficiency and highlights the need for early diagnosis and allogeneic hematopoietic stem cell transplantation in affected children.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          Human non-synonymous SNPs: server and survey.

          Human single nucleotide polymorphisms (SNPs) represent the most frequent type of human population DNA variation. One of the main goals of SNP research is to understand the genetics of the human phenotype variation and especially the genetic basis of human complex diseases. Non-synonymous coding SNPs (nsSNPs) comprise a group of SNPs that, together with SNPs in regulatory regions, are believed to have the highest impact on phenotype. Here we present a World Wide Web server to predict the effect of an nsSNP on protein structure and function. The prediction method enabled analysis of the publicly available SNP database HGVbase, which gave rise to a dataset of nsSNPs with predicted functionality. The dataset was further used to compare the effect of various structural and functional characteristics of amino acid substitutions responsible for phenotypic display of nsSNPs. We also studied the dependence of selective pressure on the structural and functional properties of proteins. We found that in our dataset the selection pressure against deleterious SNPs depends on the molecular function of the protein, although it is insensitive to several other protein features considered. The strongest selective pressure was detected for proteins involved in transcription regulation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Accounting for human polymorphisms predicted to affect protein function.

            A major interest in human genetics is to determine whether a nonsynonymous single-base nucleotide polymorphism (nsSNP) in a gene affects its protein product and, consequently, impacts the carrier's health. We used the SIFT (Sorting Intolerant From Tolerant) program to predict that 25% of 3084 nsSNPs from dbSNP, a public SNP database, would affect protein function. Some of the nsSNPs predicted to affect function were variants known to be associated with disease. Others were artifacts of SNP discovery. Two reports have indicated that there are thousands of damaging nsSNPs in an individual's human genome; we find the number is likely to be much lower.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.

              IL-21 is a type I cytokine that influences the function of T cells, NK cells, and B cells. In this study, we report that IL-21 plays a major role in stimulating the differentiation of human B cells. When human B cells were stimulated through the BCR, IL-21 induced minimal proliferation, IgD down-modulation, and small numbers of plasma cells. In contrast, after CD40 engagement, IL-21 induced extensive proliferation, class switch recombination (CSR), and plasma cell differentiation. Upon cross-linking both BCR and CD40, IL-21 induced the largest numbers of plasma cells. IL-21 drove both postswitch memory cells as well as poorly responsive naive cord blood B cells to differentiate into plasma cells. The effect of IL-21 was more potent than the combination of IL-2 and IL-10, especially when responsiveness of cord blood B cells was examined. IL-21 costimulation potently induced the expression of both B lymphocyte-induced maturation protein-1 (BLIMP-1) and activation-induced cytidine deaminase as well as the production of large amounts of IgG from B cells. Despite the induction of activation-induced cytidine deaminase and CSR, IL-21 did not induce somatic hypermutation. Finally, IL-2 enhanced the effects of IL-21, whereas IL-4 inhibited IL-21-induced plasma cell differentiation. Taken together, our data show that IL-21 plays a central role in CSR and plasma cell differentiation during T cell-dependent B cell responses.
                Bookmark

                Author and article information

                Journal
                J Exp Med
                J. Exp. Med
                jem
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                11 March 2013
                : 210
                : 3
                : 433-443
                Affiliations
                [1 ]Department of Pediatric Hematology/Oncology , [2 ]Department of Pediatric Kidney, Liver and Metabolic Diseases , [3 ]Department of Experimental Hematology , [4 ]Department of Clinical Immunology and Rheumatology , [5 ]Department of Pathology, Hannover Medical School, 30625 Hannover, Germany
                [6 ]Department of Pediatrics, Dr. von Hauner Children’s Hospital, Ludwig-Maximilians-Universität Munich, 80539 Munich, Germany
                [7 ]Immunopathogenesis Section, Laboratory of Clinical Infectious Diseases , [8 ]Laboratory of Allergic Diseases , [9 ]Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases ; [10 ]National Center for Biotechnology Information ; [11 ]National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Insitutes of Health, Bethesda, MD 20892
                [12 ]Biophysics Research Group, Technische Universität Dresden, 01062 Dresden, Germany
                [13 ]Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany
                [14 ]Institute for Medical Genetics and Human Genetics , [15 ]Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin, 10117 Berlin, Germany
                [16 ]Department of Hematology/Oncology, Genomics Core Laboratory, University Medical Center Freiburg, 79095 Freiburg, Germany
                Author notes
                CORRESPONDENCE Christoph Klein: christoph.klein@ 123456med.uni-muenchen.de

                D. Kotlarz and N. Ziętara contributed equally to this paper.

                Article
                20111229
                10.1084/jem.20111229
                3600901
                23440042
                fcc8c97a-3cd9-4a61-be15-4f2464161e10
                © 2013 Kotlarz et al.

                This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

                History
                : 16 June 2011
                : 9 January 2013
                Categories
                Brief Definitive Report

                Medicine
                Medicine

                Comments

                Comment on this article